🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “Xiyuan Hospital of China Academy of Chinese Medical Sciences” Clear

  1. Zanubrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Lymphocytic Leukemia

    phase 1 small molecule active

    1 trial

  2. [18F]F-AraG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cancer

    phase 1 small molecule active

    1 trial

  3. alpha receptor antagonist

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prostatic Hypertrophy, Benign

    phase 1 small molecule active

    1 trial

  4. anti-CD19 allo-CAR-T cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed Adult ALL

    phase 1 mab active

    1 trial

  5. autologous decidual-like NK cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Abortion, Habitual

    phase 1 mab active

    1 trial

  6. dendritic cell

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Recurrent Ovarian Cancer

    phase 1 mab active

    1 trial

  7. hUCB

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    phase 1 other completed

    1 trial

  8. haploid allogeneic NK cell therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  9. high-fat diet group（AD16 20mg）

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Alzheimer Disease

    phase 1 other completed

    1 trial

  10. mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral Vascular Disease

    phase 1 mab active

    1 trial

  11. oncolytic virus (OVV-01) injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Neoplasms

    phase 1 small molecule active

    1 trial

  12. oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule active

    6 trials

  13. peficitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  14. randomized, double-blinded, placebo-controlled

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prevention of COVID-19 Caused by SARS-CoV-2

    phase 1 mab active

    1 trial

  15. shenhuang granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    phase 1 small molecule active

    1 trial

  16. tirofiban in PV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    phase 1 small molecule active

    1 trial

  17. transcutaneous auricular vagus nerve stimulation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Participants

    phase 1 other active

    1 trial

  18. uCD7 CART

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Myeloid Leukemia (AML)

    phase 1 mab active

    1 trial

  19. ucMSCs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchopulmonary Dysplasia

    phase 1 mab active

    1 trial

  20. 0.3% ropivacaine and 50 μg dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Free Flap Reconstruction

    approved small molecule active

    1 trial

  21. 0.9% Sodium Chloride Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unstable Angina

    approved small molecule active

    1 trial

  22. 20 µg recombinant hepatitis B vaccine at months 0, 1, and 6

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab active

    3 trials

  23. 23-valent pneumococcal polysaccharide vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

  24. 30% Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources